NYSE:YCBD
cbdMD, Inc.
cbdMD, Inc.'s revenue fell 1.5% in fiscal 2025 to $19.2M while operating margin rose to −11.3%, its highest in 10 years. Free cash flow was −$1.6M, −8.5% of revenue, and the diluted share count rose 646.2%.Summary generated from cbdMD, Inc.'s SEC filings. Latest annual report filed Dec 19, 2025.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$19.2M
Revenue growth−1.5%
Revenue, 5-yr CAGR−14.5%
Gross margin62.4%
Operating margin−11.3%
Net margin−10.6%
ROICn/a
Return on equity−44.4%
Debt / equityn/a
Free cash flow−$1.6M
FCF margin−8.5%
Share count change+646.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 44 | 35 | 24 | 19 | 19 |
| Operating income | −20 | −78 | −22 | −3 | −2 |
| Net income | −23 | −70 | −23 | −4 | −2 |
| Free cash flow | −14 | −16 | −5 | −1 | −2 |
Recent filings
- 8-KEntry into a material agreement
Sep 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KEntry into a material agreement
May 20, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 14, 2026 - 4Insider transaction report
Apr 16, 2026 - 4Insider transaction report
Apr 16, 2026 - 8-KOther events
Apr 15, 2026 - 8-KDirector or officer change
Apr 1, 2026